The latest financial performance in the pharma sector shows strong Q1 FY27 results. These numbers point to improving profitability, stronger operating efficiency, and continued expansion in high-growth therapy segments
Wegovy pill has entered a new late-stage clinical trial as Novo Nordisk looks for the lowest dose that can still deliver meaningful weight loss. The study could help the company offer more flexible treatment options for people using oral...
Oncology is entering a new phase as drugmakers and research institutions push beyond conventional cancer treatment; recent developments from Moderna, Merck, Mayo Clinic, and Bengaluru-based Sravathi AI show how cancer research is expanding
FDA approvals are driving a new phase in Indian pharma. They are helping companies expand beyond domestic markets and strengthen their presence in regulated markets
Tenet Diagnostics has received a major USD 30 million investment from Tata Capital Healthcare Fund III and Swiss impact investor Blue Earth Capital AG. The deal marks a fresh push into India’s growing diagnostics market. The investment will help...
AI innovation is accelerating across India’s drug development, approvals, medical devices and specialized healthcare ecosystem
The latest pharma updates spotlight key developments in drug safety, regulatory compliance, clinical practice, disease preparedness and global ambitions
Osteoarthritis treatment could see a new stem cell-based approach after Bengaluru-based Stempeutics Research secured a US patent.
Drug approvals, MedTech innovation, and pharma legal battles are driving major healthcare developments across global and Indian markets
Indian pharmaceutical industry self-reliance stands as one of the defining achievements of India’s post-Independence healthcare journey
.jpg)
, CDSCO.jpg)